Medicare members should ask about GLP-1 Bridge eligibility (launching July 1, 2026, $50/month outside Part D)
Melanotan II Not FDA-Approved Melanotan II is not approved for any medical or cosmetic purpose in the United States, Europe, or other major markets
Halis Akturk and colleagues began noticing patterns among people with T1D in Colorado hospital emergency departments (ED) after cannabis was legalized in the state
People Seeking Non-Surgical Options: These treatments offer a safe, effective alternative to surgery with minimal downtime
Sirtuins are being studied in the context of cellular aging, metabolic health, and stress resistance, and raising NAD+ availability is one of the main strategies researchers use to support sirtuin activity
The sleep change is often described as returning to a quality of rest they had in their late 20s: falling asleep faster, fewer nighttime awakenings, and waking up feeling more genuinely rested rather than just having logged enough hours